Menu

• Ask a Health Expert about CELL-MEDIATED IMMUNE DEFICIENCY
• Post Your Side Effect related to CELL-MEDIATED IMMUNE DEFICIENCY
• CELL-MEDIATED IMMUNE DEFICIENCY and FDA Warnings
• CELL-MEDIATED IMMUNE DEFICIENCY in Patients Wiki
• Report CELL-MEDIATED IMMUNE DEFICIENCY in Drug Side Effect Survey

CELL-MEDIATED IMMUNE DEFICIENCY side effect

What is CELL-MEDIATED IMMUNE DEFICIENCY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Copaxone Side Effects Report #5388663-8
Consumer or non-health professional from GERMANY reported COPAXONE problem on July 03, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cell-mediated immune deficiency, herpes simplex, herpes zoster, hyper igm syndrome, idiopathic thrombocytopenic purpura, vaginal candidiasis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.

Copaxone Side Effects Report #5388663-8
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on July 03, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: cell-mediated immune deficiency, herpes simplex, herpes zoster, hyper igm syndrome, idiopathic thrombocytopenic purpura, vaginal candidiasis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.

Copaxone Side Effects Report #5386004-3
Consumer or non-health professional from GERMANY reported COPAXONE problem on June 27, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin m increased, cell-mediated immune deficiency, herpes simplex, thrombocytopenia, vaginal candidiasis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.

Copaxone Side Effects Report #5386004-3
COPAXONE problem was reported by a Consumer or non-health professional from GERMANY on June 27, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin m increased, cell-mediated immune deficiency, herpes simplex, thrombocytopenia, vaginal candidiasis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D) SUBCUTANEOUS. Patient recovered.


Copaxone Side Effects Report #5369949-X
Pharmacist from GERMANY reported COPAXONE problem on June 06, 2007. Female patient, 30 years of age, was diagnosed with multiple sclerosis and was treated with COPAXONE. After drug was administered, patient experienced the following problems/side effects: blood immunoglobulin m increased, cell-mediated immune deficiency, herpes zoster, idiopathic thrombocytopenic purpura, vaginal candidiasis, . COPAXONE dosage: 20 MG (20 MG, 1 IN 1 D); SUBCUTANEOUS. Patient recovered.

Cyclosporine Side Effects Report #5419139-7
CYCLOSPORINE problem was reported by a Health Professional from ITALY on Aug 13, 2007. Female patient, 59 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: arthralgia, arthritis, cell-mediated immune deficiency, creatinine renal clearance decreased, injection site ulcer, nephrotic syndrome, proteinuria, pyrexia, renal impairment, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, METHYLPREDNISOLONE. Patient recovered.